Updating the role of matrix metalloproteinases in mineralized tissue and related diseases
Authors:
- Cintia Kazuko TokuharaCTCintia Kazuko Tokuhara
- Mariana Rodrigues SantessoMSMariana Rodrigues Santesso
- Gabriela Silva Neubern de OliveiraGOGabriela Silva Neubern de Oliveira
- Talita Mendes da Silva VenturaTalita Mendes da Silva Ventura
- Julio Toshimi DoyamaJDJulio Toshimi Doyama
- Willian Fernando ZambuzziWZWillian Fernando Zambuzzi
- Rodrigo Cardoso de OliveiraRORodrigo Cardoso de Oliveira
Open Access
- 1 January 2019
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Journal of Applied Oral Science
- Vol. 27, e20180596
Abstract
Bone development and healing processes involve a complex cascade of biological events requiring well-orchestrated synergism with bone cells, growth factors, and other trophic signaling molecules and cellular structures. Beyond health processes, MMPs play several key roles in the installation of heart and blood vessel related diseases and cancer, ranging from accelerating metastatic cells to ectopic vascular mineralization by smooth muscle cells in complementary manner. The tissue inhibitors of MMPs (TIMPs) have an important role in controlling proteolysis. Paired with the post-transcriptional efficiency of specific miRNAs, they modulate MMP performance. If druggable, these molecules are suggested to be a platform for development of “smart” medications and further clinical trials. Thus, considering the pleiotropic effect of MMPs on mammals, the purpose of this review is to update the role of those multifaceted proteases in mineralized tissues in health, such as bone, and pathophysiological disorders, such as ectopic vascular calcification and cancer.Keywords
This publication has 120 references indexed in Scilit:
- Matrix metalloproteinases as therapeutic targets in protozoan parasitic infectionsPharmacology & Therapeutics, 2012
- Altered expression of microRNA‐203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activationArthritis & Rheumatism, 2010
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionSeminars in Cancer Biology, 2010
- MicroRNA‐27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytesArthritis & Rheumatism, 2010
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursorsJournal of Cellular Biochemistry, 2009
- Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritisArthritis & Rheumatism, 2008
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004